Work

Tesetaxel, a novel oral taxane, as second-line therapy for advanced gastroesophageal cancer: Activity in a dose-ranging study.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.47

Authors: Jaffer A. Ajani, Weijing Sun, Sun Young Rha, Jackie S. Baker, Mary Frances Mulcahy

Institutions: Northwestern University, The University of Texas MD Anderson Cancer Center, Yonsei University, Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590991825

Cites:

Cited by: 5

Related to: 10